The global Assisted Reproductive Technology (ART) Market is a rapidly growing sector that offers hope to millions facing infertility challenges. The market, which was valued at USD 38.9 Billion in 2024, is projected to reach USD 98.75 Billion by 2035. This growth is driven by rising global infertility rates, delayed parenthood trends, increasing awareness and acceptance of ART procedures, and continuous technological advancements. The market consists of a wide range of services and products, including IVF, ICSI, gamete donation, surrogacy, and fertility preservation techniques. Despite high costs and ethical debates, the market continues to uncover new opportunities through technological breakthroughs, expanding access, and evolving societal acceptance.